MedPath

Galsulfase

Generic Name
Galsulfase
Brand Names
Naglazyme
Drug Type
Biotech
CAS Number
552858-79-4
Unique Ingredient Identifier
59UA429E5G

Overview

Galsufase is a variant form of the polymorphic human enzyme N-acetylgalactosamine 4-sulfatase of recombinant DNA origin. Galsulfase is a glycoprotein with a molecular weight of approximately 56 kD. The recombinant protein is comprised of 495 amino acids and contains six asparagine-linked glycosylation sites, four of which carry a bis mannose-6-phosphate manose7 oligosaccharide for specific cellular recognition. Post-translational modification of Cys53 produces the catalytic amino acid residue Ca-formylglycine, which is required for enzyme activity and is conserved in all members of the sulfatase enzyme family.

Background

Galsufase is a variant form of the polymorphic human enzyme N-acetylgalactosamine 4-sulfatase of recombinant DNA origin. Galsulfase is a glycoprotein with a molecular weight of approximately 56 kD. The recombinant protein is comprised of 495 amino acids and contains six asparagine-linked glycosylation sites, four of which carry a bis mannose-6-phosphate manose7 oligosaccharide for specific cellular recognition. Post-translational modification of Cys53 produces the catalytic amino acid residue Ca-formylglycine, which is required for enzyme activity and is conserved in all members of the sulfatase enzyme family.

Indication

For the treatment of adults and children with Mucopolysaccharidosis VI.

Associated Conditions

  • Mucopolysaccharidosis Type VI

FDA Approved Products

NAGLAZYME
Manufacturer:BioMarin Pharmaceutical Inc.
Route:INTRAVENOUS
Strength:5 mg in 5 mL
Approved: 2020/04/14
NDC:68135-020

Singapore Approved Products

NAGLAZYME CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/5ML
Manufacturer:Vetter Pharma-Fertigung GmbH & Co. KG
Form:INFUSION, SOLUTION CONCENTRATE
Strength:5mg/5ml
Online:Yes
Approved: 2023/08/11
Approval:SIN16831P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath